Skip to main content
. 2018 Oct 22;8:15581. doi: 10.1038/s41598-018-33614-5

Table 2.

The detail compliance of IC and concurrent chemotherapy between two arms.

TPF regimen GP regimen P value
Induction chemotherapy
Total No. of cycles given, % 0.53
 Two cycles 11 (19.0%) 8 (14.5%)
 Three cycles 47 (81.0%) 47 (85.5%)
Concurrent chemotherapy
Total No. of cycles given, % 0.82
 One cycles 4 (6.9%) 3 (5.4%)
 Two cycles 7 (12.1%) 5 (9.1%)
 Three cycles 47 (81.0%) 47 (85.5%)